VTE Flashcards
enoxaparin (VTE prophylaxis general medical pts)
Dose?
dose: 40mg SQ QD
dalteparin (VTE prophylaxis general medical pts)
Dose?
5,000 units SQ QD
UFH (VTE prophylaxis general medical pts)
dose?
5,000 units SQ Q8h or Q12h
fondaparinux (VTE prophylaxis general medical pts)
dose?
2.5mg SQ QD
betrixaban (VTE prophylaxis general medical pts)
dose?
160mg PO x 1 dose, then 80mg PO QD for 35-42 days
What is preferred for VTE prophylaxis in orthopedic surgical pts?
LMWH
Apixaban (VTE prophylaxis in orthopedic surgical pts)
dose?
2.5mg PO BID
rivaroxaban (VTE prophylaxis in orthopedic surgical pts)
dose?
10mg PO QD
dabigatran (VTE prophylaxis in orthopedic surgical pts)
dose?
110mg PO on day of surgery, followed by 220 mg PO QD
Duration of provoked VTE Tx?
3 months
apixaban VTE Tx dosing regimen?
10mg PO BIX x 7 days, then 5mg PO BID, then option to reduce to 2.5mg PO BID after 1st 6 months
rivaroxaban VTE Tx dosing regimen?
15mg PO BID x 21 days, then 20mg PO QD, then option to reduce to 10mg PO QD after 1st 6 months
dabigatran VTE Tx dosing regimen?
first 5 days parenteral UFH, LMWH, fondaparinux (all SQ), then switch to 150mg PO BID dabigatran
Edoxaban VTE Tx dosing regimen?
first 5 days parenteral UFH, LMWH, fondaparinux (all SQ), then switch to 60mg PO daily Edoxaban
warfarin VTE Tx dosing regimen?
at least 1st 5 days UFH, LMWH, fondaparinux (all SQ), overlapped with warfarin PO QD AND INR >=2.0, then dose adjusted to INR 2.5
Parenteral anticoagulants:
What does UFH inhibit?
factor Xa dn thrombin (IIa) in a 1:1 ratio
Parenteral anticoagulants:
What does LMWH inhibit?
factor Xa and thrombin (IIa) in 3:1 ratio
Parenteral anticoagulants:
What does fondaparinux inhibit?
factor Xa (not thrombin)
UFH continuous IV infusion initial dosing?
80 units/kg bolus (max 10,000 Units) IV, followed by 18 units/kg/hr (max 2,000 units/hr)
adjust based on institution-specific heparin infusion nomogram
SQ not preferred
UFH SQ dosing?
333 units/kg bolus SQ, followed by 250 units/kg SQ Q12hr
not preferred
What aPTT results in no change to heparin dosing?
50-55
take next aPTT 6hrs after previous aPTT
UFH highlighted AE?
thrombocytopenia (HIT)
enoxaparin VTE Tx dose?
1mg/kg BID or 1.5 mg/kg SQ daily
syringes: 30, 40, 60, 80, 100, 120, 150 mg/mL available
dalteparin VTE Tx dose?
100 units/kg SQ BID or 200 units/kg SQ daily
refilled syringes: 2500, 5000, 7500, 10000, 12500, 15000, 18000 units/xmL
avoid with CrCl < 30 mL/min
fondaparinux VTE dose?
<50kg: 5mg SQ daily
50-100kg: 7.5mg SQ daily
>100kg: 10mg SQ daily
Reduce fondaparinux (VTE Tx) by how much with CrCl 30-50?
50%
CrCl < 30 avoid using
heparin induced thrombocytopenia (HIT) is what PLT count?
< 100 x 10^9/L
heparin induced thrombocytopenia (HIT) is what PLT reduction?
> 50% reduction from baseline
What score represents low probability for HIT?
< 3
What score represents intermediate probability for HIT?
4-5
What score represents high probability for HIT?
> 6
Parenteral anticoagulation monitoring:
check platelets when?
baseline and every 2-3 days between days 4-14 or until UFH/LMH d/c
What factor Xa inhibitor is not indicated for VTE Tx?
betrixaban
rivaroxaban VTE Tx dosing?
Initiation: 15mg PO BID x 21 days
Maintenance: 20mg PO daily
Extended: option to reduce to 10mg PO daily after 6 months
QD dosing avoids parenteral anticoagulation
rivaroxaban atrial fibrillation dosing?
20mg PO daily
CrCl 15-50: 15mg PO daily
CrCl < 15: avoid
QD dosing avoids parenteral anticoagulation
Take rivaroxaban with or without food?
with food to improve absorption
Apixaban VTE Tx dosing?
initiation: 10mg PO BID x 7 days
maintenance: 5mg PO BID
extended: option to reduce to 2.5mg PO BID after 6 months
BID dosing avoids parenteral anticoagulation
Apixaban atrial fibrillation dosing?
5mg PO BID
2.5mg PO BID if any 2 of the following: >= 80yo, SCr > 1.5, weight <= 60kg
BID dosing avoids parenteral anticoagulation
edoxaban VTE dosing?
Initiation: UFH, LMWH, or fondaparinux x 5-10 days
maintenance/extended: 6mg PO daily, or 30mg PO daily if <= 60kg
edoxaban atrial fibrillation dosing?
60mg PO QD
Which DOAC is minimally metabolized by CYP 3A4?
edoxaban (Savaysa)
dabigatran VTE Tx dosing?
initiation: UFH, LMWH, or fondaparinux x 5-10 days
maintenance/extended: 150mg PO BID
dabigatran atrial fibrillation dosing?
150mg PO BID
Which DOACs have interactions with dual strong P-gp and CYP3A4 inducers?
rivaroxaban, apixaban
Which DOACs have interaction with only P-gp inducers/inhibitors?
edoxaban, dabigatran
Which DOAC is favored in pts with Hx of GI bleed?
apixaban
Which DOAC causes dyspepsia?
dabigatran
DOAC contraindications?
- active bleeding
- prosthetic heart valves
DOAC limitations (use not recommended)?
- age < 18 yo
- pregnancy/lactation
DOAC requirements?
- stable renal fxn
- stable hepatic fxn
Pneumonic to remember increasing warfarin tab doses?
Please Let Greg Brown Bring Peaches To Your Wedding
pink, lavender, green, brown, blue, peach, teal, yellow, white
Warfarin inhibits synthesis of what clotting factors?
II, VII, IX, X
SNOT - seven, nine, two, ten
also inhibits synthesis of endogenous anticoagulant proteins C and S
VTE Tx: Overlap warfarin with parenteral anticoagulant how long?
minimum of 5 days AND until INR > 2.0 for 24hrs
warfarin VTE Tx dosing?
initial: 5mg PO QD
maintenance: 10mg PO daily x 2 days, then 5mg PO daily
other: 2.5mg PO QD for high risk pts
plus parenteral SQ: UFH, LMWH, fondaparinux
INR goal for VTE Tx with warfarin?
2.5 (2-3)
Warfarin:
INR < 5 with no transient factor identified
increase weekly dose 10-20%
consider 1.5-2x supplemental dose
warfarin:
INR 1.5-1.7 with no transient factor identified
increase weekly dose 5-15%
consider 1.5-2x supplemental dose
warfarin:
INR 1.8-1.9 with no transient factor identified
if previous 2 INR within range, no explanation for out of range INR, and INR does not represent increased clotting risk consider NO change
otherwise: increase weekly dose 5-105
consider 1.5-2x supplemental dose
warfarin:
INR < 1.5
INR 1.5-1.7
INR 1.8-1.9
with transient factor identified
consider 1.5-2x supplemental dose, return to previous weekly dose
warfarin:
INR 3.1-3.2
no transient factor identified
if previous 2 INR within range, no explanation for out of range INR, and INR does not represent increased clotting risk consider NO change
otherwise: decrease weekly dose by 5-10%
warfarin:
INR 3.3-3.4
no transient factor identified
decrease weekly dose 5-10%
warfarin:
INR 3.5-3.9
no transient factor identified
decrease weekly dose 5-15%, consider holding 1 dose
warfarin:
INR 3.1-3.2
INR 3.3-3.4
INR 3.5-3.9
transient factor identified
consider holding 1-2 doses, return to previous weekly dose
warfarin:
INR >= 4.0
transient factor and/or no transient factor identified
hold until INR < 3.0
decrease weekly dose by 5-20%
if pt high bleeding risk consider low-dose oral vitamin k
check INR every 1-2 days until INR < 3, then q 1-2 weeks
warfarin:
Check INR how often in inpatient setting?
q 1-3 days
warfarin:
outpatient setting in pts who are stable x 3 months check INR how often?
q 8-12 weeks
What antibiotic decreases warfarin effect?
rifampin
decreases INR
What analgesic increases warfarin effect?
tramadol
increases INR
Do antifungals increase or decrease warfarin effect?
decrease
fluconazole, ketoconazole, miconazole
d/c warfarin how many days before procedure?
5
bridge
resume warfarin 12-24hrs after procedure
warfarin perioperative management:
bridge if VTE within what time frame?
past 3 months
severe hypercoagulable state
warfarin perioperative management:
maybe bridge if VTE within what time frame?
past 3-12 months
warfarin perioperative management:
do NOT bridge if VTE within what time frame?
> 12 months ago
breastfeeding pts are optimal ___ candidates
DOAC or warfarin
warfarin
Which can be used in renal/hepatic impairment?
DOAC or warfarin
warfarin
UFH dose (VTE prophylaxis) in obesity?
7500 units SQ Q8h
no change to VTE TX doses; use actual body weight for Tx doses
VTE obesity weight/BMI?
> 100kg or BMI > 40
Avoid DOACs with what weight/BMI?
> 120kg or BMI > 40
or monitor with peak and trough
Severe renal impairment CrCl for VTE?
AKI, dialysis, or CrCl < 30ml/min
What agent is preferred for prophylaxis and acute Tx of VTE in pts with severe renal impairment?
UFH
warfarin may also be used; dose adjusted based on INR
Avoid what two hirudin derivatives in pts with severe renal impairment?
dalteparin, fondaparinux
What pregnancy category is warfarin?
X
safe in lactation
What agent is preferred for VTE Tx in cancer pts?
LMWH
VTE:
What is category 1 mono therapy?
dalteparin
VTE:
What is category 1 combo therapy?
LMWH + edoxaban